跳至主要内容
临床试验/NCT07530081
NCT07530081进行中(未招募)不适用

The Impact of Oral Probiotics on Improving the Quality of Life in Patients With Dysmenorrhea.

Glac Biotech Co., Ltd1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年3月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
150
试验地点
1
主要终点
Changes in Numerical Rating Scale(NRS) scores

研究概览

简要总结

Menstrual pain is mainly divided into primary dysmenorrhea and secondary dysmenorrhea, the former is caused by menstrual uterine muscle movement; the latter is caused by certain diseases, such as Endometriosis, Uterine fibroids and Pelvic inflammatory disease. Menstrual pain has been a troubling issue for many women. The most common type of menstrual pain is at the lower abdomen. For some girls, menstrual pain is accompanied by nausea, diarrhea, fatigue, headache, flatulence, etc.

In addition to menstrual pain, Premenstrual syndrome (PMS) is also one of the problems that affect women's physical and mental health. PMS, as the name suggests, these symptoms appear before menstruation. During the periods, the symptoms will gradually disappear and before the next menstruation it will appear again.

About 80% women in Taiwan have experienced with menstrual pain or premenstrual discomfort. It affects the physical, psychological and social status of most women, and the degree of menstrual pain can also affect mood, sleep quality,school and work efficiency. Although there are many ways to relieve menstrual pain, hot compresses or oral painkillers, contraceptive pills, etc., but these medications are not without side effects.

Probiotics are defined as live microorganisms that, in sufficient quantities, benefit the health of the host. They are mainly bacteria that produce lactic acid, including Lactobacilli, Bifidobacteria, and Saccharomyces boulardii. Most studies have pointed out that probiotics can reduce the severity of gastrointestinal symptoms. Some studies have also pointed out that probiotics can improve physical and psychological functions, such as depression and sleep quality. In addition, animal experiments have shown that probiotics can regulate GABA in mice A and GABA B receptor expression to alter mood.

This study aims to explore whether probiotic supplementation can improve menstrual pain and menstrual discomfort symptoms. If these common menstrual problems can be improved by probiotics, it will be a great significance to improve the quality of life of women. The trial lasts for 8 menstrual cycles, including 2 menstrual cycles in the screening period, 4 menstrual cycles in the test period and 2 menstrual cycles in the follow-up period. This trial will performed in China Medical University Hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female aged between 20 and 65 years.
  • Regular menstrual cycles.
  • During the last three menstrual periods, self-reported dysmenorrhea with a pain score ≥ 3 on the Numeric Rating Scale (NRS).
  • Able to use effective contraception during the study period.
  • Willing to participate in the study and has signed the informed consent form.

排除标准

  • Planning to become pregnant, currently pregnant, or in the postpartum stage with menstruation not yet resumed.
  • Postmenopausal women.
  • Irregular menstrual cycles (cycle length < 21 days or > 40 days).
  • Currently taking any psychiatric medications, oral contraceptives, menstrual regulation drugs, weight-loss drugs, or antibiotics.
  • Consumption of probiotic-related products within the past 1 month (including drops, tablets, capsules, powder, or yogurt and fermented milk products).

研究组 & 干预措施

High dose Probiotic

Experimental

干预措施: High dose Probiotic (Dietary Supplement)

Low dose Probiotic

Experimental

干预措施: Low dose probiotic (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Changes in Numerical Rating Scale(NRS) scores

时间窗: Baseline and the 1st, 2nd, 3rd, 4th, 5th, and 6th menstrual cycles post-intervention

Changes in Numerical Rating Scale(NRS) scores were assessed before and the 1st, 2nd, 3rd, 4th, 5th, and 6th menstrual cycles post-intervention. The minimum value is "0" and maximum value is "10", higher scores mean a worse outcome.

Changes in the premenstrual symptoms screening tool(PSST) scores

时间窗: Baseline and the 1st, 2nd, 3rd, 4th, 5th, and 6th menstrual cycles post-intervention

Changes in the premenstrual symptoms screening tool(PSST) scores were assessed before and the 1st, 2nd, 3rd, 4th, 5th, and 6th menstrual cycles post-intervention. The minimum value is "19" and maximum value is "76", higher scores mean a worse outcome.

Changes in Menstrual Distress Questionnaire(MDQ) scores

时间窗: Baseline and the 1st, 2nd, 3rd, 4th, 5th, and 6th menstrual cycles post-intervention

Changes in Menstrual Distress Questionnaire(MDQ) scores were assessed before and the 1st, 2nd, 3rd, 4th, 5th, and 6th menstrual cycles post-intervention. The minimum value is "16" and maximum value is "64", higher scores mean a worse outcome.

Changes in Short-Form McGill Pain Questionnaire(SF-MPQ) scores

时间窗: Baseline and the 1st, 2nd, 3rd, 4th, 5th, and 6th menstrual cycles post-intervention

Changes in Short-Form McGill Pain Questionnaire(SF-MPQ) scores were assessed before and the 1st, 2nd, 3rd, 4th, 5th, and 6th menstrual cycles post-intervention. The minimum value is "15" and maximum value is "60", higher scores mean a worse outcome.

次要结局

  • Changes in Pittsburgh Sleep Quality Index (PSQI) scores.(Baseline and the 1st, 2nd, 3rd, 4th, 5th, and 6th menstrual cycles post-intervention)
  • Analysis of gut microbiota composition(Baseline and the fourth menstrual cycle post-intervention.)
  • Analysis of vaginal microbiota composition(Baseline and the fourth menstrual cycle post-intervention.)
  • Analysis of vaginal pH value change(Baseline and the fourth menstrual cycle post-intervention.)
  • Changes in blood biochemical parameters(Baseline and the fourth menstrual cycle post-intervention.)
  • Changes in urinary inflammatory markers.(Baseline and the fourth menstrual cycle post-intervention.)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Hsieh-Hsun Ho

Research and Development Director

Glac Biotech Co., Ltd

研究点 (1)

Loading locations...

相似试验